Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Drug-Delivery Technology Market Size Outlook: How Quickly Will Revenue Expand Through 2030?
The drug-delivery technology market size has seen swift expansion in recent years. It will grow from $54.24 billion in 2025 to $60.27 billion in 2026 at a compound annual growth rate (CAGR) of 11.1%. This historical growth can be linked to factors such as an increase in chronic diseases, developments in pharmaceutical formulations, a need for enhanced patient compliance, the expansion of injectable therapies, and innovation in medical devices.
The drug-delivery technology market is projected for significant expansion in the coming years. Its value is anticipated to reach $91.41 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.0%. This growth over the forecast period is largely due to the emergence of personalized medicine, the rise of biologics and biosimilars, increasing demand for long-acting drug delivery methods, advancements in implantable technologies, and the growing embrace of home care treatments. Key developments anticipated within the forecast period encompass targeted drug delivery systems, controlled and sustained release formulations, drug delivery devices designed around patient needs, minimally invasive delivery approaches, and sophisticated implantable drug systems.
Get A Free Sample Report With In-Depth Market Insights:
Drug-Delivery Technology Market Expansion Drivers: What’s Shaping Future Growth?
The rising incidence of chronic diseases is anticipated to drive the expansion of the drug-delivery technology market. These enduring medical conditions typically advance slowly and demand continuous management. The increased occurrence of chronic diseases results from sedentary lifestyles, which diminish physical activity and contribute to obesity and related health concerns. Drug-delivery technology improves the management of chronic diseases by facilitating targeted delivery, controlled substance release, enhanced bioavailability, and minimized side effects, ultimately boosting treatment efficacy, patient compliance, and overall disease control. For illustration, data from July 2024, published in the Australian Burden of Disease Study 2023 by the Australian Institute of Health and Welfare (AIHW), indicated that chronic conditions represented 91% of non-fatal burden (years lived with disability) and 78% of fatal burden (years of life lost) in 2023. Thus, the escalating prevalence of chronic diseases serves as a key driver for the growth of the drug-delivery technology market.
Drug-Delivery Technology Market Segment Performance And Emerging Opportunities
The drug-delivery technology market covered in this report is segmented –
1) By Type: Oral, Injectable, Topical, Ocular, Nasal, Pulmonary, Transmucosal, Implantable
2) By Application: Cardiovascular Diseases, Oncology, Urology, Diabetes, Central Nervous System (CNS), Ophthalmology, Infections, Other Applications
3) By End User: Hospitals, Clinics, Diagnostic Centers, Home Care Settings, Other End Users
Subsegments:
1) By Oral: Tablets, Capsules, Solutions, Suspensions, Powders, Gels
2) By Injectable: Conventional Injection, Self-Injection, Long-Acting Injection
3) By Topical: Creams, Gels, Lotions, Patches, Ointments
4) By Ocular: Eye Drops, Ointments, Gels, Inserts, Implants
5) By Nasal: Sprays, Drops, Powders, Gels
6) By Pulmonary: Metered Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers
7) By Transmucosal: Buccal, Sublingual, Rectal, Vaginal
8) By Implantable: Biodegradable Implants, Non-Biodegradable Implants, Drug-Eluting Stents
Drug-Delivery Technology Market Strategic Trends: What Defines The Next Growth Phase?
Leading companies within the drug-delivery technology market are concentrating on creating novel products, such as prefilled injection devices, to boost patient comfort, refine dosing precision, and guarantee safer drug delivery. A prefilled injection device is a medical apparatus that comes with a predetermined dose of medication already loaded, removing the requirement for manual drug preparation before use. For example, in February 2023, Phillips-Medisize LLC, a US-based medical equipment manufacturing company, unveiled a new disposable pen injector intended for high-volume production. This injector boasts a compact and adaptable design, featuring adjustable dosing and push-button colors to support a range of treatments, including diabetes, fertility, growth hormones, obesity, and osteoporosis. The device’s objective is to assist pharmaceutical companies in speeding up market entry by providing an economical, ready-to-use option, thereby lowering commercialization expenses and associated risks.
Drug-Delivery Technology Market Key Players: Which Companies Lead Industry Competition?
Major companies operating in the drug-delivery technology market are Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., AstraZeneca Plc, Novartis AG, GlaxoSmithKline Plc., Cipla Limited, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Vertex Pharmaceuticals Incorporated, Chiesi Farmaceutici S.p.A., United Therapeutics Corporation, Mallinckrodt Pharmaceuticals Plc., Lupin Pharmaceuticals, Inc., Glenmark Pharmaceuticals Limited, Alkermes plc., Halozyme Therapeutics Inc., Sunovion Pharmaceuticals Inc., and Circassia Pharmaceuticals Plc.
View The Full Drug-Delivery Technology Market Report:
Drug-Delivery Technology Market Regional Breakdown: Where Is Demand Concentrated?
North America was the largest region in the drug-delivery technology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug-delivery technology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
